SC348293 · Active · incorporated 18 years, 1 month ago · Midlothian
Biotech Biotech & Life Sciences Drug Discovery Series B+
Censo Biotechnologies merged with Axol Bioscience, which provides iPSC-derived cells and contract research services for drug discovery.
Axol Bioscience is a private limited company registered at Companies House under number SC348293, incorporated on 9 September 2008, with a registered office in Midlothian. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 149 filings for this company, including 8 funding rounds. Its most recent round closed in December 2025, raising £718k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 8 | Dec 2025 | £718k | £4.99 |
| Round 7 | Jul 2024 | £3.8m | £4.42 |
| Round 6 | Oct 2023 | £1.5m | £7.50 |
| Round 5 | Apr 2022 | £3.2m | £10.50 |
| Round 4 | Apr 2021 | £12.7m | £10.50 |
| Round 3 | Apr 2020 | £1.9m | £7.67 |
Showing the 6 most recent of 8 rounds.
Showing the 13 most recent of 149 filings.
See the complete cap table with every shareholder, founder tags, dilution across 40 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.